Kodikaz

Targeted, Modular, Effective

New York, United States · Founded 2018 · $10.8M raised

Headquarters
New York, New York
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$10.8M
Last Round
$10.5M SeedAug 2021
Rounds
2

About

Kodikaz Therapeutic Solutions is a New York-based non-viral gene therapy company developing its proprietary Zip-Code™ Technology platform — a first-in-class, cell-specific delivery system for gene and cell therapy applications. Unlike viral delivery approaches, Zip-Codes are derived from an endogenous human mechanism that enables precise targeting of therapeutic payloads to specific cancer cell types while sparing healthy cells. The company is focused on advancing next-generation cancer therapies with Emory University-licensed technology and has acquired AmorChem's RNA Zipcode delivery technology.

Summary

Kodikaz is a Biotech company based in New York, United States, founded in 2018. It has raised $10.8M in total across 2 rounds, most recently a $10.5M Seed round in Aug 2021. Investors include Illumina Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase I (NSF)Aug 2021
$256K

Sign up to see all 2 rounds

Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kodikaz on Indexed.vc
<a href="https://indexed.vc/companies/kodikaz"><img src="https://indexed.vc/api/badge/company/kodikaz" alt="Kodikaz on Indexed.vc" width="260" height="76" /></a>